Psoriasis Guide

Psoriasis Medication Section


 


Social bookmarking
You like it? Share it!
socialize it

Newsletter

Subscribe to our newsletter AND receive our exclusive Special Report on Psoriasis
Name:
Email:



Main Psoriasis Medication sponsors


 

Latest Psoriasis Medication Link Added

INSERT YOUR OWN BANNER HERE

Submit your link on Psoriasis Medication!



 

Welcome to Psoriasis Guide

 

Psoriasis Medication Article

Thumbnail example. For a permanent link to this article, or to bookmark it for further reading, click here.

The Difference between Scalp Psoriasis and Dandruff

from:

There are some people who mistake a breakout of thick flakes on their scalps as a dandruff problem, and they will sometimes try to treat this with the use of normal, everyday dandruff solutions like shampoos, conditioners, creams and other such items that are used to help get rid of these white flakes. What they do not know is that the dandruff they are treating may not be actually dandruff but rather scalp psoriasis.

Scalp psoriasis is a kind of skin ailment that manifests itself in symptoms like red patches on your scalp that is often covered or accompanied by white or silvery flakes, skin or scalp that may bleed due to dryness and cracking, and a burning or itching feeling. On the other hand, dandruff is a skin problem that bears some similarities to scalp psoriasis, but to a lesser extent. Dandruff can also be called seborrheic dermatitis or seborrheic eczema, depending on how severe the case may be. Symptoms of dandruff or seborrheic eczema may also include the usual flaking of the skin, itchiness and sometimes yellowish scales that are found near the hair shaft.

While it may seem like these two are rather different, and they do have certain notable differences, they can actually be treated with the same treatments, depending on the severity of the person's scalp psoriasis or the dandruff problem. The most notable difference between the two problems is probably the thickness of the scales that the skin condition produces. Scalp psoriasis tends to produce thicker scales than dandruff. This means that while they can both be treated with the usual dandruff shampoos that contain ketoconazole or selenium sulfide, sufferers of scalp psoriasis may need to use more than just shampoos to help keep the scaling, the skin cracking and bleeding down.

Another distinct difference between dandruff and scalp psoriasis is the fact that while a person suffering from dandruff may have an itchy scalp that has a layer of flakes on it, a person with scalp psoriasis will often have more than just his scalp to worry about since this condition usually has other manifestations on the person's body in the form of psoriasis scales. These can usually be found on a person's elbows, fingers and even on his knees, and they may require treatments with the use of ointments or creams that are formulated for such problems.

Diagnosing whether a person is suffering from seborrheic eczema or from psoriasis can be done with a little scrutiny of the other parts of the person's body for other flaky regions. Should these be absent, the person need not worry too much since there are treatments that are pretty effective on any of these two scalp problems.


Other Psoriasis Medication related Articles

Psoriasis Treatments
Psoriasis Cure
Scalp Psoriasis
Psoriasis Treatment
Plaque Psoriasis

Do you want to contribute to our site : submit your articles HERE


 

Psoriasis Medication News

World Market for Prescription Dermatological Drugs, 8th Edition (Antiacne, Antiaging, Dermatitis, Hair Loss, Psoriasis ...

NEW YORK, May 14, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: World Market for Prescription Dermatological Drugs, 8th Edition (Antiacne, ...

Read more...


Newer, More Expensive Psoriasis Drugs Only Slightly More Effective Than Older Therapies Under Real World Conditions

PHILADELPHIA — More expensive biologic treatments for psoriasis were only marginally more effective than standard treatments, according to a new study led by researchers in the Perelman School of Medicine at the University of Pennsylvania . Researchers found that previously reported response rates from randomized controlled trials were higher than results in a clinical, real-world setting.

Read more...


Dermatological Drugs: World Market Prospects 2012-2022

NEW YORK, May 2, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Dermatological Drugs: World Market Prospects 2012-2022 http://www.reportlinker.com/p0788690/Dermatological-Drugs-World-Market-Prospects-2012-2022.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_MedicationReport ...

Read more...


FDA panel favors novel arthritis drug from Pfizer

Federal health advisers said Wednesday that a first-of-a-kind drug from Pfizer appears to be safe and effective for patients with rheumatoid arthritis, though they recommended follow-up studies to gauge the pill's long-term side effects.

Read more...


New Phase 3 Study Results Show Anti-TNF SIMPONI® Induced Clinical Response in Adults With Moderately to Severely ...

SAN DIEGO, May 21, 2012 /PRNewswire/ -- New study findings presented today show that subcutaneous induction regimens of the anti-tumor necrosis factor (TNF)-alpha therapy SIMPONI® (golimumab) induced clinical ...

Read more...